Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.
Identifieur interne : 003C02 ( Main/Exploration ); précédent : 003C01; suivant : 003C03Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.
Auteurs : RBID : pubmed:10093860English descriptors
- KwdEn :
- Carcinoid Tumor (genetics), Carcinoid Tumor (radiography), Carcinoid Tumor (radionuclide imaging), Carcinoid Tumor (surgery), Hormones (diagnostic use), Humans, Indium Radioisotopes (diagnostic use), Male, Middle Aged, Multiple Endocrine Neoplasia Type 1 (genetics), Multiple Endocrine Neoplasia Type 1 (radiography), Multiple Endocrine Neoplasia Type 1 (radionuclide imaging), Multiple Endocrine Neoplasia Type 1 (surgery), Octreotide (diagnostic use), Pentetic Acid (diagnostic use), Receptors, Somatostatin, Somatostatin (analogs & derivatives), Somatostatin (diagnostic use), Thymus Gland (radiography), Thymus Gland (radionuclide imaging), Thymus Neoplasms (genetics), Thymus Neoplasms (radiography), Thymus Neoplasms (radionuclide imaging), Thymus Neoplasms (surgery), Tomography, X-Ray Computed.
- MESH :
- chemical , analogs & derivatives : Somatostatin.
- chemical , diagnostic use : Hormones, Indium Radioisotopes, Octreotide, Pentetic Acid, Somatostatin.
- genetics : Carcinoid Tumor, Multiple Endocrine Neoplasia Type 1, Thymus Neoplasms.
- radiography : Carcinoid Tumor, Multiple Endocrine Neoplasia Type 1, Thymus Gland, Thymus Neoplasms.
- radionuclide imaging : Carcinoid Tumor, Multiple Endocrine Neoplasia Type 1, Thymus Gland, Thymus Neoplasms.
- surgery : Carcinoid Tumor, Multiple Endocrine Neoplasia Type 1, Thymus Neoplasms.
- Humans, Male, Middle Aged, Receptors, Somatostatin, Tomography, X-Ray Computed.
Abstract
Thymic carcinoid tumours constitute less than 1% of all carcinoids, and differ markedly from true thymomas in natural history, morphology, prognosis and therapeutic options. New clinical and diagnostic modalities are described in two brothers with thymic carcinoid associated with multiple endocrine neoplasia syndrome. Octreotide scintigraphy proved useful for diagnosis and follow-up, and somatostatin receptor positivity may provide new prospects for treatment of non-resectable or recurrent tumour.
PubMed: 10093860
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.</title><author><name sortKey="Satta, J" uniqKey="Satta J">J Satta</name><affiliation wicri:level="1"><nlm:affiliation>Department of Surgery, University of Oulu, Finland.</nlm:affiliation><country xml:lang="fr">Finlande</country><wicri:regionArea>Department of Surgery, University of Oulu</wicri:regionArea></affiliation></author><author><name sortKey="Ahonen, A" uniqKey="Ahonen A">A Ahonen</name></author><author><name sortKey="Parkkila, S" uniqKey="Parkkila S">S Parkkila</name></author><author><name sortKey="Leinonen, L" uniqKey="Leinonen L">L Leinonen</name></author><author><name sortKey="Apaja Sarkkinen, M" uniqKey="Apaja Sarkkinen M">M Apaja-Sarkkinen</name></author><author><name sortKey="Lepoj Rvi, M" uniqKey="Lepoj Rvi M">M Lepojärvi</name></author><author><name sortKey="Juvonen, T" uniqKey="Juvonen T">T Juvonen</name></author></titleStmt><publicationStmt><date when="1999">1999</date><idno type="RBID">pubmed:10093860</idno><idno type="pmid">10093860</idno><idno type="wicri:Area/Main/Corpus">003F28</idno><idno type="wicri:Area/Main/Curation">003F28</idno><idno type="wicri:Area/Main/Exploration">003C02</idno></publicationStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Carcinoid Tumor (genetics)</term><term>Carcinoid Tumor (radiography)</term><term>Carcinoid Tumor (radionuclide imaging)</term><term>Carcinoid Tumor (surgery)</term><term>Hormones (diagnostic use)</term><term>Humans</term><term>Indium Radioisotopes (diagnostic use)</term><term>Male</term><term>Middle Aged</term><term>Multiple Endocrine Neoplasia Type 1 (genetics)</term><term>Multiple Endocrine Neoplasia Type 1 (radiography)</term><term>Multiple Endocrine Neoplasia Type 1 (radionuclide imaging)</term><term>Multiple Endocrine Neoplasia Type 1 (surgery)</term><term>Octreotide (diagnostic use)</term><term>Pentetic Acid (diagnostic use)</term><term>Receptors, Somatostatin</term><term>Somatostatin (analogs & derivatives)</term><term>Somatostatin (diagnostic use)</term><term>Thymus Gland (radiography)</term><term>Thymus Gland (radionuclide imaging)</term><term>Thymus Neoplasms (genetics)</term><term>Thymus Neoplasms (radiography)</term><term>Thymus Neoplasms (radionuclide imaging)</term><term>Thymus Neoplasms (surgery)</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Somatostatin</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Hormones</term><term>Indium Radioisotopes</term><term>Octreotide</term><term>Pentetic Acid</term><term>Somatostatin</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Carcinoid Tumor</term><term>Multiple Endocrine Neoplasia Type 1</term><term>Thymus Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiography" xml:lang="en"><term>Carcinoid Tumor</term><term>Multiple Endocrine Neoplasia Type 1</term><term>Thymus Gland</term><term>Thymus Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Carcinoid Tumor</term><term>Multiple Endocrine Neoplasia Type 1</term><term>Thymus Gland</term><term>Thymus Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Carcinoid Tumor</term><term>Multiple Endocrine Neoplasia Type 1</term><term>Thymus Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Receptors, Somatostatin</term><term>Tomography, X-Ray Computed</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thymic carcinoid tumours constitute less than 1% of all carcinoids, and differ markedly from true thymomas in natural history, morphology, prognosis and therapeutic options. New clinical and diagnostic modalities are described in two brothers with thymic carcinoid associated with multiple endocrine neoplasia syndrome. Octreotide scintigraphy proved useful for diagnosis and follow-up, and somatostatin receptor positivity may provide new prospects for treatment of non-resectable or recurrent tumour.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">10093860</PMID><DateCreated><Year>1999</Year><Month>05</Month><Day>06</Day></DateCreated><DateCompleted><Year>1999</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1401-7431</ISSN><JournalIssue CitedMedium="Print"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>1999</Year></PubDate></JournalIssue><Title>Scandinavian cardiovascular journal : SCJ</Title><ISOAbbreviation>Scand. Cardiovasc. J.</ISOAbbreviation></Journal><ArticleTitle>Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.</ArticleTitle><Pagination><MedlinePgn>49-53</MedlinePgn></Pagination><Abstract><AbstractText>Thymic carcinoid tumours constitute less than 1% of all carcinoids, and differ markedly from true thymomas in natural history, morphology, prognosis and therapeutic options. New clinical and diagnostic modalities are described in two brothers with thymic carcinoid associated with multiple endocrine neoplasia syndrome. Octreotide scintigraphy proved useful for diagnosis and follow-up, and somatostatin receptor positivity may provide new prospects for treatment of non-resectable or recurrent tumour.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Satta</LastName><ForeName>J</ForeName><Initials>J</Initials><Affiliation>Department of Surgery, University of Oulu, Finland.</Affiliation></Author><Author ValidYN="Y"><LastName>Ahonen</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Parkkila</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Leinonen</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Apaja-Sarkkinen</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lepojärvi</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Juvonen</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType>Case Reports</PublicationType><PublicationType>Journal Article</PublicationType><PublicationType>Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>NORWAY</Country><MedlineTA>Scand Cardiovasc J</MedlineTA><NlmUniqueID>9708377</NlmUniqueID><ISSNLinking>1401-7431</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Indium Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance>Receptors, Somatostatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>138661-02-6</RegistryNumber><NameOfSubstance>pentetreotide</NameOfSubstance></Chemical><Chemical><RegistryNumber>51110-01-1</RegistryNumber><NameOfSubstance>Somatostatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>7A314HQM0I</RegistryNumber><NameOfSubstance>Pentetic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>RWM8CCW8GP</RegistryNumber><NameOfSubstance>Octreotide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N">Carcinoid Tumor</DescriptorName><QualifierName MajorTopicYN="N">genetics</QualifierName><QualifierName MajorTopicYN="N">radiography</QualifierName><QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName><QualifierName MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Hormones</DescriptorName><QualifierName MajorTopicYN="Y">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName><QualifierName MajorTopicYN="Y">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Multiple Endocrine Neoplasia Type 1</DescriptorName><QualifierName MajorTopicYN="N">genetics</QualifierName><QualifierName MajorTopicYN="N">radiography</QualifierName><QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName><QualifierName MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Octreotide</DescriptorName><QualifierName MajorTopicYN="Y">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Pentetic Acid</DescriptorName><QualifierName MajorTopicYN="Y">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Receptors, Somatostatin</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Somatostatin</DescriptorName><QualifierName MajorTopicYN="Y">analogs & derivatives</QualifierName><QualifierName MajorTopicYN="N">diagnostic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Thymus Gland</DescriptorName><QualifierName MajorTopicYN="N">radiography</QualifierName><QualifierName MajorTopicYN="N">radionuclide imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Thymus Neoplasms</DescriptorName><QualifierName MajorTopicYN="N">genetics</QualifierName><QualifierName MajorTopicYN="N">radiography</QualifierName><QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName><QualifierName MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>15</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1999</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1999</Year><Month>3</Month><Day>27</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1999</Year><Month>3</Month><Day>27</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">10093860</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003C02 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003C02 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= *** parameter Area/wikiCode missing ***
|area= IndiumV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:10093860
|texte= Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:10093860" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a IndiumV2
| This area was generated with Dilib version V0.5.76. |  |